Lifecore Biomedical
LFCR
LFCR
96 hedge funds and large institutions have $265M invested in Lifecore Biomedical in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 40 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less call options, than puts
Call options by funds: $12K | Put options by funds: $14K
33% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 40
Holders
96
Holding in Top 10
2
Calls
$12K
Puts
$14K
Top Buyers
| 1 | +$5.73M | |
| 2 | +$4.43M | |
| 3 | +$3.85M | |
| 4 |
AI
Acuitas Investments
Seattle,
Washington
|
+$2.9M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$1.54M |
Top Sellers
| 1 | -$3.31M | |
| 2 | -$2.92M | |
| 3 | -$2.08M | |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$1.65M |
| 5 |
Morgan Stanley
New York
|
-$1.36M |